EA200300021A1 - Фармацевтические дезинфицирующие препараты на основе уснината натрия и лекарственных растений и способы их изготовления - Google Patents

Фармацевтические дезинфицирующие препараты на основе уснината натрия и лекарственных растений и способы их изготовления

Info

Publication number
EA200300021A1
EA200300021A1 EA200300021A EA200300021A EA200300021A1 EA 200300021 A1 EA200300021 A1 EA 200300021A1 EA 200300021 A EA200300021 A EA 200300021A EA 200300021 A EA200300021 A EA 200300021A EA 200300021 A1 EA200300021 A1 EA 200300021A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical
sodium
methods
medicinal plants
unique
Prior art date
Application number
EA200300021A
Other languages
English (en)
Other versions
EA006582B1 (ru
Inventor
Слободан Станкович
Ивана Джорджевич
Зоран Коцич
Original Assignee
Ад "Здравлье" Фармацеутско-Хемийска Индустрийя, Центар За Истраживанье И Развой
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ад "Здравлье" Фармацеутско-Хемийска Индустрийя, Центар За Истраживанье И Развой filed Critical Ад "Здравлье" Фармацеутско-Хемийска Индустрийя, Центар За Истраживанье И Развой
Publication of EA200300021A1 publication Critical patent/EA200300021A1/ru
Publication of EA006582B1 publication Critical patent/EA006582B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/235—Foeniculum (fennel)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к области фармацевтических дезинфицирующих препаратов на основе уснината натрия и лекарственных растений (шалфея Salfia officinalis L, фенхеля Foeniculum vulgare L, тимьяна Thimus vulgaris L, мяты Mentha piperita L) или ментола, которые используются как общее дезинфицирующее средство для наружного пользования, а также при воспалениях верхних дыхательных путей и полости рта, вызванных действием патогенных микроорганизмов. В изобретении показаны способы изготовления препарата в форме драже - ориблета, таблеток, геля, аэрозоля, а также в качестве субстрата для дезодорантов, ароматическо-антисептической жидкости для дезинфекции в форме влажных салфеток интимного пользования, пудры для детей и других форм соответствующего назначения.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200300021A 2000-06-15 2000-11-03 Фармацевтический дезинфицирующий препарат на основе уснината натрия и лекарственных растений, (его варианты) и способы их изготовления EA006582B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
YUP037300 2000-06-15
PCT/YU2000/000022 WO2001095900A1 (en) 2000-06-15 2000-11-03 Pharmaceutical disinfectants comprising usnic and essential oils

Publications (2)

Publication Number Publication Date
EA200300021A1 true EA200300021A1 (ru) 2003-10-30
EA006582B1 EA006582B1 (ru) 2006-02-24

Family

ID=37012150

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300021A EA006582B1 (ru) 2000-06-15 2000-11-03 Фармацевтический дезинфицирующий препарат на основе уснината натрия и лекарственных растений, (его варианты) и способы их изготовления

Country Status (8)

Country Link
EP (1) EP1294373B1 (ru)
AU (1) AU2001212552A1 (ru)
DE (1) DE60022689T2 (ru)
EA (1) EA006582B1 (ru)
HR (1) HRPK20030006B1 (ru)
RS (1) RS49778B (ru)
SI (1) SI1294373T1 (ru)
WO (1) WO2001095900A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1190190C (zh) * 2001-11-23 2005-02-23 王卫 一种抗病毒、抗菌的斑蝥酸酐药物组合物及其制备方法
AU2003263162B2 (en) 2002-10-24 2009-05-07 Immupharm A/S Pharmaceutical compositions comprising flavonoids and menthol
WO2004043436A1 (fr) * 2002-11-13 2004-05-27 Fanzi Cong Aerosol a usage medical comprenant une huile essentielle provenant d'une plante et sa preparation
GB0303677D0 (en) * 2003-02-18 2003-03-19 Quest Int Flavoured products
US8147877B2 (en) 2006-06-01 2012-04-03 Ohso Clean, Inc. Essential oils based disinfecting compositions having tuberculocidal and fungicidal efficacies
US7465697B1 (en) 2006-11-02 2008-12-16 Ohsoclean, Inc. Essential oils based cleaning and disinfecting compositions
IT201900021852A1 (it) * 2019-11-21 2021-05-21 Vestatis Gmbh Composizione di estratti naturali avente attività antibatterica o batteriostatica anche per batteri Gram-negativi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2354517A1 (de) * 1973-10-31 1975-05-28 Handelsgesellschaft Schlosser Kosmetisches praeparat
IT1204901B (it) * 1986-06-25 1989-03-10 Iscofar Sas Composizioni contenenti acido usnico o suoi derivati atte all'impiego nel trattamento della carie dentaria
RO96751B1 (ro) * 1986-12-29 1989-04-30 Institutul De Cercetari Chimico-Farmaceutice Apa de gura cu extracte de plante
FR2662939B1 (fr) * 1990-06-08 1992-09-18 Beaussier Yann Gel anti-inflammatoire et son procede de fabrication.
WO2000003612A2 (de) * 1998-07-13 2000-01-27 Joerg Peter Schuer Antimikrobielle zusammensetzung

Also Published As

Publication number Publication date
HRP20030006A2 (en) 2003-04-30
EP1294373A1 (en) 2003-03-26
DE60022689T2 (de) 2006-06-22
YU37300A (sh) 2002-12-10
EA006582B1 (ru) 2006-02-24
RS49778B (sr) 2008-06-05
AU2001212552A1 (en) 2001-12-24
DE60022689D1 (de) 2005-10-20
SI1294373T1 (sl) 2006-02-28
HRPK20030006B1 (en) 2004-08-31
EP1294373B1 (en) 2005-09-14
WO2001095900A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
ATE418324T1 (de) Mucoadhäsive xyloglucan-haltige formulierung für medizinprodukte und pharmazeutische darreichungsformen
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
BR0015188A (pt) Composições farmacêuticas
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
CY2011014I1 (el) Φαρμακοτεχνικες μορφες σταθερου φαρμακευτικου διαλυματος για υπο πιεση μετρημενης δοσης συσκευες εισπνοης
BR0207726A (pt) Sais farmacêuticos
MEP36608A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
SE0001899D0 (sv) New compounds
BR0108427A (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
ID23806A (id) Komposisi-komposisi farmasi untuk pemberian oral yang terdiri dari bahan aktif dan siklodekstrin
CR8371A (es) Formulaciones de medicamento que contienen saborizantes con mejores propiedades farmaceuticas
ATE531361T1 (de) Neue pharmazeutische dosierform und herstellungsverfahren
BR0114043A (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas
ECSP034826A (es) Método para fabricar una composición farmacéutica de dosis baja
BR0311984A (pt) Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação
ECSP066860A (es) Formulaciones de matriz oral que comprenden licarbazepina
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
EA200300021A1 (ru) Фармацевтические дезинфицирующие препараты на основе уснината натрия и лекарственных растений и способы их изготовления
CL2004001843A1 (es) Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax
BR0110069A (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas
PT1212336E (pt) Aglomerados esfericos de telitromicina seu procedimento de preparacao e sua aplicacao na preparacao de formas farmaceuticas
ATE296814T1 (de) Ionenkanal modulierende mittel
SV2001000253A (es) Pirazolo (4,3-e) diazepinas sustituidas novedosas, composiciones farmaceuticas que las contienen, su uso como productos medicinales y procesos para prepararlas
ATE338567T1 (de) Pharmazeutische zubereitungen, wirkstoffe enthaltend, die sich für unerlaubte verabreichung anbieten

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG RU

MK4A Patent expired

Designated state(s): MD